Pharma & Healthcare
Global Contraceptives Market Research Report 2026
- Jan 17, 26
- ID: 688006
- Pages: 120
- Figures: 119
- Views: 3
This report delivers a comprehensive overview of the global Contraceptives market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Contraceptives. The Contraceptives market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Contraceptives market comprehensively. Regional market sizes by Type, by End User, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Contraceptives manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End User, and by region.
Market Segmentation
By Company
Bayer
Pfizer
Teva
Actavis
Gedeon Richter
ZiZhu
Baijingyu
Sine
Reckitt
AbbVie
Church & Dwight
Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Segment by Type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
by End User
15–24 years
25–34 years
35–44 years
Above 44 years
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End User, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Contraceptives manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Contraceptives sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by End User, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Contraceptives market comprehensively. Regional market sizes by Type, by End User, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Contraceptives manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End User, and by region.
Market Segmentation
By Company
Bayer
Pfizer
Teva
Actavis
Gedeon Richter
ZiZhu
Baijingyu
Sine
Reckitt
AbbVie
Church & Dwight
Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Segment by Type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
by End User
15–24 years
25–34 years
35–44 years
Above 44 years
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End User, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Contraceptives manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Contraceptives sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by End User, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Contraceptives Market Overview
1.1 Product Definition
1.2 Contraceptives by Type
1.2.1 Global Contraceptives Market Value by Type: 2025 vs 2032
1.2.2 Pills
1.2.3 Injectable
1.2.4 Condoms
1.2.5 Vaginal Rings
1.2.6 IUDs
1.2.7 Subdermal Implants
1.2.8 Others
1.3 Contraceptives by End User
1.3.1 Global Contraceptives Market Value by End User: 2025 vs 2032
1.3.2 15–24 years
1.3.3 25–34 years
1.3.4 35–44 years
1.3.5 Above 44 years
1.4 Global Contraceptives Market Size Estimates and Forecasts
1.4.1 Global Contraceptives Revenue 2021–2032
1.4.2 Global Contraceptives Sales 2021–2032
1.4.3 Global Contraceptives Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Contraceptives Market Competition by Manufacturers
2.1 Global Contraceptives Sales Market Share by Manufacturers (2021–2026)
2.2 Global Contraceptives Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Contraceptives Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Contraceptives, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Contraceptives, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Contraceptives, Product Types and Applications
2.7 Global Key Manufacturers of Contraceptives, Date of Entry into the Industry
2.8 Global Contraceptives Market Competitive Situation and Trends
2.8.1 Global Contraceptives Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Contraceptives Players Market Share by Revenue
2.8.3 Global Contraceptives Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Contraceptives Market Scenario by Region
3.1 Global Contraceptives Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Contraceptives Sales by Region: 2021–2032
3.2.1 Global Contraceptives Sales by Region: 2021–2026
3.2.2 Global Contraceptives Sales by Region: 2027–2032
3.3 Global Contraceptives Revenue by Region: 2021–2032
3.3.1 Global Contraceptives Revenue by Region: 2021–2026
3.3.2 Global Contraceptives Revenue by Region: 2027–2032
3.4 North America Contraceptives Market Facts & Figures by Country
3.4.1 North America Contraceptives Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Contraceptives Sales by Country (2021–2032)
3.4.3 North America Contraceptives Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Contraceptives Market Facts & Figures by Country
3.5.1 Europe Contraceptives Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Contraceptives Sales by Country (2021–2032)
3.5.3 Europe Contraceptives Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contraceptives Market Facts & Figures by Region
3.6.1 Asia Pacific Contraceptives Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Contraceptives Sales by Region (2021–2032)
3.6.3 Asia Pacific Contraceptives Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Contraceptives Market Facts & Figures by Country
3.7.1 Latin America Contraceptives Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Contraceptives Sales by Country (2021–2032)
3.7.3 Latin America Contraceptives Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contraceptives Market Facts & Figures by Country
3.8.1 Middle East and Africa Contraceptives Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Contraceptives Sales by Country (2021–2032)
3.8.3 Middle East and Africa Contraceptives Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Contraceptives Sales by Type (2021–2032)
4.1.1 Global Contraceptives Sales by Type (2021–2026)
4.1.2 Global Contraceptives Sales by Type (2027–2032)
4.1.3 Global Contraceptives Sales Market Share by Type (2021–2032)
4.2 Global Contraceptives Revenue by Type (2021–2032)
4.2.1 Global Contraceptives Revenue by Type (2021–2026)
4.2.2 Global Contraceptives Revenue by Type (2027–2032)
4.2.3 Global Contraceptives Revenue Market Share by Type (2021–2032)
4.3 Global Contraceptives Price by Type (2021–2032)
5 Segment by End User
5.1 Global Contraceptives Sales by End User (2021–2032)
5.1.1 Global Contraceptives Sales by End User (2021–2026)
5.1.2 Global Contraceptives Sales by End User (2027–2032)
5.1.3 Global Contraceptives Sales Market Share by End User (2021–2032)
5.2 Global Contraceptives Revenue by End User (2021–2032)
5.2.1 Global Contraceptives Revenue by End User (2021–2026)
5.2.2 Global Contraceptives Revenue by End User (2027–2032)
5.2.3 Global Contraceptives Revenue Market Share by End User (2021–2032)
5.3 Global Contraceptives Price by End User (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer Contraceptives Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Contraceptives Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Teva Contraceptives Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Company Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Actavis Contraceptives Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Gedeon Richter
6.5.1 Gedeon Richter Company Information
6.5.2 Gedeon Richter Description and Business Overview
6.5.3 Gedeon Richter Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Gedeon Richter Contraceptives Product Portfolio
6.5.5 Gedeon Richter Recent Developments/Updates
6.6 ZiZhu
6.6.1 ZiZhu Company Information
6.6.2 ZiZhu Description and Business Overview
6.6.3 ZiZhu Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ZiZhu Contraceptives Product Portfolio
6.6.5 ZiZhu Recent Developments/Updates
6.7 Baijingyu
6.7.1 Baijingyu Company Information
6.7.2 Baijingyu Description and Business Overview
6.7.3 Baijingyu Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Baijingyu Contraceptives Product Portfolio
6.7.5 Baijingyu Recent Developments/Updates
6.8 Sine
6.8.1 Sine Company Information
6.8.2 Sine Description and Business Overview
6.8.3 Sine Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sine Contraceptives Product Portfolio
6.8.5 Sine Recent Developments/Updates
6.9 Reckitt
6.9.1 Reckitt Company Information
6.9.2 Reckitt Description and Business Overview
6.9.3 Reckitt Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Reckitt Contraceptives Product Portfolio
6.9.5 Reckitt Recent Developments/Updates
6.10 AbbVie
6.10.1 AbbVie Company Information
6.10.2 AbbVie Description and Business Overview
6.10.3 AbbVie Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 AbbVie Contraceptives Product Portfolio
6.10.5 AbbVie Recent Developments/Updates
6.11 Church & Dwight
6.11.1 Church & Dwight Company Information
6.11.2 Church & Dwight Description and Business Overview
6.11.3 Church & Dwight Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Church & Dwight Contraceptives Product Portfolio
6.11.5 Church & Dwight Recent Developments/Updates
6.12 Cooper Companies
6.12.1 Cooper Companies Company Information
6.12.2 Cooper Companies Description and Business Overview
6.12.3 Cooper Companies Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Cooper Companies Contraceptives Product Portfolio
6.12.5 Cooper Companies Recent Developments/Updates
6.13 TherapeuticsMD
6.13.1 TherapeuticsMD Company Information
6.13.2 TherapeuticsMD Description and Business Overview
6.13.3 TherapeuticsMD Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 TherapeuticsMD Contraceptives Product Portfolio
6.13.5 TherapeuticsMD Recent Developments/Updates
6.14 Afaxys
6.14.1 Afaxys Company Information
6.14.2 Afaxys Description and Business Overview
6.14.3 Afaxys Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Afaxys Contraceptives Product Portfolio
6.14.5 Afaxys Recent Developments/Updates
6.15 Mithra Pharmaceuticals
6.15.1 Mithra Pharmaceuticals Company Information
6.15.2 Mithra Pharmaceuticals Description and Business Overview
6.15.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
6.15.5 Mithra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contraceptives Industry Chain Analysis
7.2 Contraceptives Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contraceptives Production Mode & Process Analysis
7.4 Contraceptives Sales and Marketing
7.4.1 Contraceptives Sales Channels
7.4.2 Contraceptives Distributors
7.5 Contraceptives Customer Analysis
8 Contraceptives Market Dynamics
8.1 Contraceptives Industry Trends
8.2 Contraceptives Market Drivers
8.3 Contraceptives Market Challenges
8.4 Contraceptives Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Contraceptives by Type
1.2.1 Global Contraceptives Market Value by Type: 2025 vs 2032
1.2.2 Pills
1.2.3 Injectable
1.2.4 Condoms
1.2.5 Vaginal Rings
1.2.6 IUDs
1.2.7 Subdermal Implants
1.2.8 Others
1.3 Contraceptives by End User
1.3.1 Global Contraceptives Market Value by End User: 2025 vs 2032
1.3.2 15–24 years
1.3.3 25–34 years
1.3.4 35–44 years
1.3.5 Above 44 years
1.4 Global Contraceptives Market Size Estimates and Forecasts
1.4.1 Global Contraceptives Revenue 2021–2032
1.4.2 Global Contraceptives Sales 2021–2032
1.4.3 Global Contraceptives Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Contraceptives Market Competition by Manufacturers
2.1 Global Contraceptives Sales Market Share by Manufacturers (2021–2026)
2.2 Global Contraceptives Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Contraceptives Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Contraceptives, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Contraceptives, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Contraceptives, Product Types and Applications
2.7 Global Key Manufacturers of Contraceptives, Date of Entry into the Industry
2.8 Global Contraceptives Market Competitive Situation and Trends
2.8.1 Global Contraceptives Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Contraceptives Players Market Share by Revenue
2.8.3 Global Contraceptives Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Contraceptives Market Scenario by Region
3.1 Global Contraceptives Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Contraceptives Sales by Region: 2021–2032
3.2.1 Global Contraceptives Sales by Region: 2021–2026
3.2.2 Global Contraceptives Sales by Region: 2027–2032
3.3 Global Contraceptives Revenue by Region: 2021–2032
3.3.1 Global Contraceptives Revenue by Region: 2021–2026
3.3.2 Global Contraceptives Revenue by Region: 2027–2032
3.4 North America Contraceptives Market Facts & Figures by Country
3.4.1 North America Contraceptives Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Contraceptives Sales by Country (2021–2032)
3.4.3 North America Contraceptives Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Contraceptives Market Facts & Figures by Country
3.5.1 Europe Contraceptives Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Contraceptives Sales by Country (2021–2032)
3.5.3 Europe Contraceptives Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contraceptives Market Facts & Figures by Region
3.6.1 Asia Pacific Contraceptives Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Contraceptives Sales by Region (2021–2032)
3.6.3 Asia Pacific Contraceptives Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Contraceptives Market Facts & Figures by Country
3.7.1 Latin America Contraceptives Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Contraceptives Sales by Country (2021–2032)
3.7.3 Latin America Contraceptives Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contraceptives Market Facts & Figures by Country
3.8.1 Middle East and Africa Contraceptives Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Contraceptives Sales by Country (2021–2032)
3.8.3 Middle East and Africa Contraceptives Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Contraceptives Sales by Type (2021–2032)
4.1.1 Global Contraceptives Sales by Type (2021–2026)
4.1.2 Global Contraceptives Sales by Type (2027–2032)
4.1.3 Global Contraceptives Sales Market Share by Type (2021–2032)
4.2 Global Contraceptives Revenue by Type (2021–2032)
4.2.1 Global Contraceptives Revenue by Type (2021–2026)
4.2.2 Global Contraceptives Revenue by Type (2027–2032)
4.2.3 Global Contraceptives Revenue Market Share by Type (2021–2032)
4.3 Global Contraceptives Price by Type (2021–2032)
5 Segment by End User
5.1 Global Contraceptives Sales by End User (2021–2032)
5.1.1 Global Contraceptives Sales by End User (2021–2026)
5.1.2 Global Contraceptives Sales by End User (2027–2032)
5.1.3 Global Contraceptives Sales Market Share by End User (2021–2032)
5.2 Global Contraceptives Revenue by End User (2021–2032)
5.2.1 Global Contraceptives Revenue by End User (2021–2026)
5.2.2 Global Contraceptives Revenue by End User (2027–2032)
5.2.3 Global Contraceptives Revenue Market Share by End User (2021–2032)
5.3 Global Contraceptives Price by End User (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer Contraceptives Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pfizer Contraceptives Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Teva Contraceptives Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Company Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Actavis Contraceptives Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Gedeon Richter
6.5.1 Gedeon Richter Company Information
6.5.2 Gedeon Richter Description and Business Overview
6.5.3 Gedeon Richter Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Gedeon Richter Contraceptives Product Portfolio
6.5.5 Gedeon Richter Recent Developments/Updates
6.6 ZiZhu
6.6.1 ZiZhu Company Information
6.6.2 ZiZhu Description and Business Overview
6.6.3 ZiZhu Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 ZiZhu Contraceptives Product Portfolio
6.6.5 ZiZhu Recent Developments/Updates
6.7 Baijingyu
6.7.1 Baijingyu Company Information
6.7.2 Baijingyu Description and Business Overview
6.7.3 Baijingyu Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Baijingyu Contraceptives Product Portfolio
6.7.5 Baijingyu Recent Developments/Updates
6.8 Sine
6.8.1 Sine Company Information
6.8.2 Sine Description and Business Overview
6.8.3 Sine Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sine Contraceptives Product Portfolio
6.8.5 Sine Recent Developments/Updates
6.9 Reckitt
6.9.1 Reckitt Company Information
6.9.2 Reckitt Description and Business Overview
6.9.3 Reckitt Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Reckitt Contraceptives Product Portfolio
6.9.5 Reckitt Recent Developments/Updates
6.10 AbbVie
6.10.1 AbbVie Company Information
6.10.2 AbbVie Description and Business Overview
6.10.3 AbbVie Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 AbbVie Contraceptives Product Portfolio
6.10.5 AbbVie Recent Developments/Updates
6.11 Church & Dwight
6.11.1 Church & Dwight Company Information
6.11.2 Church & Dwight Description and Business Overview
6.11.3 Church & Dwight Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Church & Dwight Contraceptives Product Portfolio
6.11.5 Church & Dwight Recent Developments/Updates
6.12 Cooper Companies
6.12.1 Cooper Companies Company Information
6.12.2 Cooper Companies Description and Business Overview
6.12.3 Cooper Companies Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Cooper Companies Contraceptives Product Portfolio
6.12.5 Cooper Companies Recent Developments/Updates
6.13 TherapeuticsMD
6.13.1 TherapeuticsMD Company Information
6.13.2 TherapeuticsMD Description and Business Overview
6.13.3 TherapeuticsMD Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 TherapeuticsMD Contraceptives Product Portfolio
6.13.5 TherapeuticsMD Recent Developments/Updates
6.14 Afaxys
6.14.1 Afaxys Company Information
6.14.2 Afaxys Description and Business Overview
6.14.3 Afaxys Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Afaxys Contraceptives Product Portfolio
6.14.5 Afaxys Recent Developments/Updates
6.15 Mithra Pharmaceuticals
6.15.1 Mithra Pharmaceuticals Company Information
6.15.2 Mithra Pharmaceuticals Description and Business Overview
6.15.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
6.15.5 Mithra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contraceptives Industry Chain Analysis
7.2 Contraceptives Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contraceptives Production Mode & Process Analysis
7.4 Contraceptives Sales and Marketing
7.4.1 Contraceptives Sales Channels
7.4.2 Contraceptives Distributors
7.5 Contraceptives Customer Analysis
8 Contraceptives Market Dynamics
8.1 Contraceptives Industry Trends
8.2 Contraceptives Market Drivers
8.3 Contraceptives Market Challenges
8.4 Contraceptives Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Contraceptives Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Contraceptives Market Value by End User (US$ Million), 2025 vs 2032
Table 3. Global Contraceptives Market Competitive Situation by Manufacturers in 2025
Table 4. Global Contraceptives Sales (M Units) of Key Manufacturers (2021–2026)
Table 5. Global Contraceptives Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Contraceptives Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Contraceptives Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Contraceptives Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Contraceptives, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Contraceptives, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Contraceptives, Product Types and Applications
Table 12. Global Key Manufacturers of Contraceptives, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Contraceptives Companies by Tier (Tier 1, Tier 2, Tier 3), based on Contraceptives Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Contraceptives Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Contraceptives Sales by Region (M Units), 2021–2026
Table 18. Global Contraceptives Sales Market Share by Region (2021–2026)
Table 19. Global Contraceptives Sales by Region (M Units), 2027–2032
Table 20. Global Contraceptives Sales Market Share by Region (2027–2032)
Table 21. Global Contraceptives Revenue by Region (US$ Million), 2021–2026
Table 22. Global Contraceptives Revenue Market Share by Region (2021–2026)
Table 23. Global Contraceptives Revenue by Region (US$ Million), 2027–2032
Table 24. Global Contraceptives Revenue Market Share by Region (2027–2032)
Table 25. North America Contraceptives Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Contraceptives Sales by Country (M Units), 2021–2026
Table 27. North America Contraceptives Sales by Country (M Units), 2027–2032
Table 28. North America Contraceptives Revenue by Country (US$ Million), 2021–2026
Table 29. North America Contraceptives Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Contraceptives Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Contraceptives Sales by Country (M Units), 2021–2026
Table 32. Europe Contraceptives Sales by Country (M Units), 2027–2032
Table 33. Europe Contraceptives Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Contraceptives Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Contraceptives Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Contraceptives Sales by Region (M Units), 2021–2026
Table 37. Asia Pacific Contraceptives Sales by Region (M Units), 2027–2032
Table 38. Asia Pacific Contraceptives Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Contraceptives Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Contraceptives Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Contraceptives Sales by Country (M Units), 2021–2026
Table 42. Latin America Contraceptives Sales by Country (M Units), 2027–2032
Table 43. Latin America Contraceptives Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Contraceptives Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Contraceptives Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Contraceptives Sales by Country (M Units), 2021–2026
Table 47. Middle East and Africa Contraceptives Sales by Country (M Units), 2027–2032
Table 48. Middle East and Africa Contraceptives Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Contraceptives Revenue by Country (US$ Million), 2027–2032
Table 50. Global Contraceptives Sales (M Units) by Type (2021–2026)
Table 51. Global Contraceptives Sales (M Units) by Type (2027–2032)
Table 52. Global Contraceptives Sales Market Share by Type (2021–2026)
Table 53. Global Contraceptives Sales Market Share by Type (2027–2032)
Table 54. Global Contraceptives Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Contraceptives Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Contraceptives Revenue Market Share by Type (2021–2026)
Table 57. Global Contraceptives Revenue Market Share by Type (2027–2032)
Table 58. Global Contraceptives Price (USD/Unit) by Type (2021–2026)
Table 59. Global Contraceptives Price (USD/Unit) by Type (2027–2032)
Table 60. Global Contraceptives Sales (M Units) by End User (2021–2026)
Table 61. Global Contraceptives Sales (M Units) by End User (2027–2032)
Table 62. Global Contraceptives Sales Market Share by End User (2021–2026)
Table 63. Global Contraceptives Sales Market Share by End User (2027–2032)
Table 64. Global Contraceptives Revenue (US$ Million) by End User (2021–2026)
Table 65. Global Contraceptives Revenue (US$ Million) by End User (2027–2032)
Table 66. Global Contraceptives Revenue Market Share by End User (2021–2026)
Table 67. Global Contraceptives Revenue Market Share by End User (2027–2032)
Table 68. Global Contraceptives Price (USD/Unit) by End User (2021–2026)
Table 69. Global Contraceptives Price (USD/Unit) by End User (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Bayer Contraceptives Product
Table 74. Bayer Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Contraceptives Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Teva Contraceptives Product
Table 84. Teva Recent Developments/Updates
Table 85. Actavis Company Information
Table 86. Actavis Description and Business Overview
Table 87. Actavis Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Actavis Contraceptives Product
Table 89. Actavis Recent Developments/Updates
Table 90. Gedeon Richter Company Information
Table 91. Gedeon Richter Description and Business Overview
Table 92. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Gedeon Richter Contraceptives Product
Table 94. Gedeon Richter Recent Developments/Updates
Table 95. ZiZhu Company Information
Table 96. ZiZhu Description and Business Overview
Table 97. ZiZhu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. ZiZhu Contraceptives Product
Table 99. ZiZhu Recent Developments/Updates
Table 100. Baijingyu Company Information
Table 101. Baijingyu Description and Business Overview
Table 102. Baijingyu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Baijingyu Contraceptives Product
Table 104. Baijingyu Recent Developments/Updates
Table 105. Sine Company Information
Table 106. Sine Description and Business Overview
Table 107. Sine Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Sine Contraceptives Product
Table 109. Sine Recent Developments/Updates
Table 110. Reckitt Company Information
Table 111. Reckitt Description and Business Overview
Table 112. Reckitt Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Reckitt Contraceptives Product
Table 114. Reckitt Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. AbbVie Contraceptives Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Church & Dwight Company Information
Table 121. Church & Dwight Description and Business Overview
Table 122. Church & Dwight Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Church & Dwight Contraceptives Product
Table 124. Church & Dwight Recent Developments/Updates
Table 125. Cooper Companies Company Information
Table 126. Cooper Companies Description and Business Overview
Table 127. Cooper Companies Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Cooper Companies Contraceptives Product
Table 129. Cooper Companies Recent Developments/Updates
Table 130. TherapeuticsMD Company Information
Table 131. TherapeuticsMD Description and Business Overview
Table 132. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. TherapeuticsMD Contraceptives Product
Table 134. TherapeuticsMD Recent Developments/Updates
Table 135. Afaxys Company Information
Table 136. Afaxys Description and Business Overview
Table 137. Afaxys Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 138. Afaxys Contraceptives Product
Table 139. Afaxys Recent Developments/Updates
Table 140. Mithra Pharmaceuticals Company Information
Table 141. Mithra Pharmaceuticals Description and Business Overview
Table 142. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 143. Mithra Pharmaceuticals Contraceptives Product
Table 144. Mithra Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Contraceptives Distributors List
Table 148. Contraceptives Customers List
Table 149. Contraceptives Market Trends
Table 150. Contraceptives Market Drivers
Table 151. Contraceptives Market Challenges
Table 152. Contraceptives Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Contraceptives
Figure 2. Global Contraceptives Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Contraceptives Market Share by Type: 2025 & 2032
Figure 4. Pills Product Picture
Figure 5. Injectable Product Picture
Figure 6. Condoms Product Picture
Figure 7. Vaginal Rings Product Picture
Figure 8. IUDs Product Picture
Figure 9. Subdermal Implants Product Picture
Figure 10. Others Product Picture
Figure 11. Global Contraceptives Market Value by End User (US$ Million), 2021–2032
Figure 12. Global Contraceptives Market Share by End User: 2025 & 2032
Figure 13. 15–24 years
Figure 14. 25–34 years
Figure 15. 35–44 years
Figure 16. Above 44 years
Figure 17. Global Contraceptives Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Contraceptives Market Size (US$ Million), 2021–2032
Figure 19. Global Contraceptives Sales (M Units), 2021–2032
Figure 20. Global Contraceptives Average Price (USD/Unit), 2021–2032
Figure 21. Contraceptives Report Years Considered
Figure 22. Contraceptives Sales Share by Manufacturers in 2025
Figure 23. Global Contraceptives Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Contraceptives Players: Market Share by Revenue in Contraceptives in 2025
Figure 25. Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Contraceptives Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Contraceptives Sales Market Share by Country (2021–2032)
Figure 28. North America Contraceptives Revenue Market Share by Country (2021–2032)
Figure 29. U.S. Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Contraceptives Sales Market Share by Country (2021–2032)
Figure 32. Europe Contraceptives Revenue Market Share by Country (2021–2032)
Figure 33. Germany Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Contraceptives Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Contraceptives Revenue Market Share by Region (2021–2032)
Figure 40. China Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Taiwan Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Indonesia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Thailand Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Malaysia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Philippines Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Latin America Contraceptives Sales Market Share by Country (2021–2032)
Figure 51. Latin America Contraceptives Revenue Market Share by Country (2021–2032)
Figure 52. Mexico Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Brazil Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Argentina Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Middle East and Africa Contraceptives Sales Market Share by Country (2021–2032)
Figure 56. Middle East and Africa Contraceptives Revenue Market Share by Country (2021–2032)
Figure 57. Turkey Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Saudi Arabia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. U.A.E Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Global Sales Market Share of Contraceptives by Type (2021–2032)
Figure 61. Global Revenue Market Share of Contraceptives by Type (2021–2032)
Figure 62. Global Contraceptives Price (USD/Unit) by Type (2021–2032)
Figure 63. Global Sales Market Share of Contraceptives by End User (2021–2032)
Figure 64. Global Revenue Market Share of Contraceptives by End User (2021–2032)
Figure 65. Global Contraceptives Price (USD/Unit) by End User (2021–2032)
Figure 66. Contraceptives Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Contraceptives Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Contraceptives Market Value by End User (US$ Million), 2025 vs 2032
Table 3. Global Contraceptives Market Competitive Situation by Manufacturers in 2025
Table 4. Global Contraceptives Sales (M Units) of Key Manufacturers (2021–2026)
Table 5. Global Contraceptives Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Contraceptives Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Contraceptives Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Contraceptives Average Price (USD/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Contraceptives, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Contraceptives, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Contraceptives, Product Types and Applications
Table 12. Global Key Manufacturers of Contraceptives, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Contraceptives Companies by Tier (Tier 1, Tier 2, Tier 3), based on Contraceptives Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Contraceptives Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Contraceptives Sales by Region (M Units), 2021–2026
Table 18. Global Contraceptives Sales Market Share by Region (2021–2026)
Table 19. Global Contraceptives Sales by Region (M Units), 2027–2032
Table 20. Global Contraceptives Sales Market Share by Region (2027–2032)
Table 21. Global Contraceptives Revenue by Region (US$ Million), 2021–2026
Table 22. Global Contraceptives Revenue Market Share by Region (2021–2026)
Table 23. Global Contraceptives Revenue by Region (US$ Million), 2027–2032
Table 24. Global Contraceptives Revenue Market Share by Region (2027–2032)
Table 25. North America Contraceptives Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Contraceptives Sales by Country (M Units), 2021–2026
Table 27. North America Contraceptives Sales by Country (M Units), 2027–2032
Table 28. North America Contraceptives Revenue by Country (US$ Million), 2021–2026
Table 29. North America Contraceptives Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Contraceptives Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Contraceptives Sales by Country (M Units), 2021–2026
Table 32. Europe Contraceptives Sales by Country (M Units), 2027–2032
Table 33. Europe Contraceptives Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Contraceptives Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Contraceptives Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Contraceptives Sales by Region (M Units), 2021–2026
Table 37. Asia Pacific Contraceptives Sales by Region (M Units), 2027–2032
Table 38. Asia Pacific Contraceptives Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Contraceptives Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Contraceptives Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Contraceptives Sales by Country (M Units), 2021–2026
Table 42. Latin America Contraceptives Sales by Country (M Units), 2027–2032
Table 43. Latin America Contraceptives Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Contraceptives Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Contraceptives Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Contraceptives Sales by Country (M Units), 2021–2026
Table 47. Middle East and Africa Contraceptives Sales by Country (M Units), 2027–2032
Table 48. Middle East and Africa Contraceptives Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Contraceptives Revenue by Country (US$ Million), 2027–2032
Table 50. Global Contraceptives Sales (M Units) by Type (2021–2026)
Table 51. Global Contraceptives Sales (M Units) by Type (2027–2032)
Table 52. Global Contraceptives Sales Market Share by Type (2021–2026)
Table 53. Global Contraceptives Sales Market Share by Type (2027–2032)
Table 54. Global Contraceptives Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Contraceptives Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Contraceptives Revenue Market Share by Type (2021–2026)
Table 57. Global Contraceptives Revenue Market Share by Type (2027–2032)
Table 58. Global Contraceptives Price (USD/Unit) by Type (2021–2026)
Table 59. Global Contraceptives Price (USD/Unit) by Type (2027–2032)
Table 60. Global Contraceptives Sales (M Units) by End User (2021–2026)
Table 61. Global Contraceptives Sales (M Units) by End User (2027–2032)
Table 62. Global Contraceptives Sales Market Share by End User (2021–2026)
Table 63. Global Contraceptives Sales Market Share by End User (2027–2032)
Table 64. Global Contraceptives Revenue (US$ Million) by End User (2021–2026)
Table 65. Global Contraceptives Revenue (US$ Million) by End User (2027–2032)
Table 66. Global Contraceptives Revenue Market Share by End User (2021–2026)
Table 67. Global Contraceptives Revenue Market Share by End User (2027–2032)
Table 68. Global Contraceptives Price (USD/Unit) by End User (2021–2026)
Table 69. Global Contraceptives Price (USD/Unit) by End User (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 73. Bayer Contraceptives Product
Table 74. Bayer Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 78. Pfizer Contraceptives Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 83. Teva Contraceptives Product
Table 84. Teva Recent Developments/Updates
Table 85. Actavis Company Information
Table 86. Actavis Description and Business Overview
Table 87. Actavis Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 88. Actavis Contraceptives Product
Table 89. Actavis Recent Developments/Updates
Table 90. Gedeon Richter Company Information
Table 91. Gedeon Richter Description and Business Overview
Table 92. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 93. Gedeon Richter Contraceptives Product
Table 94. Gedeon Richter Recent Developments/Updates
Table 95. ZiZhu Company Information
Table 96. ZiZhu Description and Business Overview
Table 97. ZiZhu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 98. ZiZhu Contraceptives Product
Table 99. ZiZhu Recent Developments/Updates
Table 100. Baijingyu Company Information
Table 101. Baijingyu Description and Business Overview
Table 102. Baijingyu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 103. Baijingyu Contraceptives Product
Table 104. Baijingyu Recent Developments/Updates
Table 105. Sine Company Information
Table 106. Sine Description and Business Overview
Table 107. Sine Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 108. Sine Contraceptives Product
Table 109. Sine Recent Developments/Updates
Table 110. Reckitt Company Information
Table 111. Reckitt Description and Business Overview
Table 112. Reckitt Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 113. Reckitt Contraceptives Product
Table 114. Reckitt Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 118. AbbVie Contraceptives Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Church & Dwight Company Information
Table 121. Church & Dwight Description and Business Overview
Table 122. Church & Dwight Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 123. Church & Dwight Contraceptives Product
Table 124. Church & Dwight Recent Developments/Updates
Table 125. Cooper Companies Company Information
Table 126. Cooper Companies Description and Business Overview
Table 127. Cooper Companies Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 128. Cooper Companies Contraceptives Product
Table 129. Cooper Companies Recent Developments/Updates
Table 130. TherapeuticsMD Company Information
Table 131. TherapeuticsMD Description and Business Overview
Table 132. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 133. TherapeuticsMD Contraceptives Product
Table 134. TherapeuticsMD Recent Developments/Updates
Table 135. Afaxys Company Information
Table 136. Afaxys Description and Business Overview
Table 137. Afaxys Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 138. Afaxys Contraceptives Product
Table 139. Afaxys Recent Developments/Updates
Table 140. Mithra Pharmaceuticals Company Information
Table 141. Mithra Pharmaceuticals Description and Business Overview
Table 142. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
Table 143. Mithra Pharmaceuticals Contraceptives Product
Table 144. Mithra Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Contraceptives Distributors List
Table 148. Contraceptives Customers List
Table 149. Contraceptives Market Trends
Table 150. Contraceptives Market Drivers
Table 151. Contraceptives Market Challenges
Table 152. Contraceptives Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Contraceptives
Figure 2. Global Contraceptives Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Contraceptives Market Share by Type: 2025 & 2032
Figure 4. Pills Product Picture
Figure 5. Injectable Product Picture
Figure 6. Condoms Product Picture
Figure 7. Vaginal Rings Product Picture
Figure 8. IUDs Product Picture
Figure 9. Subdermal Implants Product Picture
Figure 10. Others Product Picture
Figure 11. Global Contraceptives Market Value by End User (US$ Million), 2021–2032
Figure 12. Global Contraceptives Market Share by End User: 2025 & 2032
Figure 13. 15–24 years
Figure 14. 25–34 years
Figure 15. 35–44 years
Figure 16. Above 44 years
Figure 17. Global Contraceptives Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Contraceptives Market Size (US$ Million), 2021–2032
Figure 19. Global Contraceptives Sales (M Units), 2021–2032
Figure 20. Global Contraceptives Average Price (USD/Unit), 2021–2032
Figure 21. Contraceptives Report Years Considered
Figure 22. Contraceptives Sales Share by Manufacturers in 2025
Figure 23. Global Contraceptives Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global Contraceptives Players: Market Share by Revenue in Contraceptives in 2025
Figure 25. Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global Contraceptives Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America Contraceptives Sales Market Share by Country (2021–2032)
Figure 28. North America Contraceptives Revenue Market Share by Country (2021–2032)
Figure 29. U.S. Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe Contraceptives Sales Market Share by Country (2021–2032)
Figure 32. Europe Contraceptives Revenue Market Share by Country (2021–2032)
Figure 33. Germany Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific Contraceptives Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific Contraceptives Revenue Market Share by Region (2021–2032)
Figure 40. China Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Taiwan Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Indonesia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Thailand Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Malaysia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Philippines Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Latin America Contraceptives Sales Market Share by Country (2021–2032)
Figure 51. Latin America Contraceptives Revenue Market Share by Country (2021–2032)
Figure 52. Mexico Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Brazil Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Argentina Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Middle East and Africa Contraceptives Sales Market Share by Country (2021–2032)
Figure 56. Middle East and Africa Contraceptives Revenue Market Share by Country (2021–2032)
Figure 57. Turkey Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Saudi Arabia Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. U.A.E Contraceptives Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Global Sales Market Share of Contraceptives by Type (2021–2032)
Figure 61. Global Revenue Market Share of Contraceptives by Type (2021–2032)
Figure 62. Global Contraceptives Price (USD/Unit) by Type (2021–2032)
Figure 63. Global Sales Market Share of Contraceptives by End User (2021–2032)
Figure 64. Global Revenue Market Share of Contraceptives by End User (2021–2032)
Figure 65. Global Contraceptives Price (USD/Unit) by End User (2021–2032)
Figure 66. Contraceptives Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232